MedTrace Logo

Effects of Integrated Treatment by Traditional Chinese and Western Medicine in Reducing Cardiovascular Events

NCT01715376 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1042

Last updated 2020-05-27

No results posted yet for this study

Summary

Compared with standardized western medical drug therapy, this study is mainly about whether the combination of standardized western medical drug therapy and Chinese medical continued treatment, can further decrease the rate of cardiovascular events for stable angina patients and change the condition of angina.

Conditions

Sponsors & Collaborators

  • Changchun University of Chinese Medicine

    lead OTHER

Principal Investigators

  • deng yue · dirctor

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-09-30
Completion
2015-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01715376 on ClinicalTrials.gov